A Safety, Tolerability, and Efficacy Study of E-islet 01 in Participants With Type 1 Diabetes

NCT07126873 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 1
Impaired Hypoglycemic Awareness
Severe Hypoglycemia

Interventions

BIOLOGICAL: Allogeneic Human E-islet (E-islet 01)

Sponsor

EndoCell Therapeutics, Inc.